Sánchez announces vaccine plan for all of Spain with 13,000 administration points

“Single strategy” plan will begin in January and aims to give “equal access” to all priority groups

Spanish president Pedro Sánchez speaks at the G-20 summit (image by Borja Puig de la Bellacasa/Pool Moncloa)
Spanish president Pedro Sánchez speaks at the G-20 summit (image by Borja Puig de la Bellacasa/Pool Moncloa) / ACN

ACN | Barcelona

November 22, 2020 07:35 PM

The president of the Spanish government, Pedro Sánchez, has announced a “single strategy” vaccine plan for all of Spain which will begin in January. 

In an appearance after the G20 summit, Sánchez said that the strategy provides for about 13,000 vaccination points across the country with the aim of ensuring "equal access" for all priority groups

A registration system for monitoring those who receive the vaccine will also be promoted. Details of the entire strategy will be announced on Tuesday.

The plan will be agreed upon by various experts and representatives from the regions across Spain, the Interterritorial Council. 

Sanchez outlined that it is the European Union that negotiates for vaccines on behalf of the 27 member states, so right now there are five different contracts on the table. All indications are, however, that the most advanced vaccine is Pfizer. 

Of the total, Spain will get 10% available, news that, according to the president of the Spanish government, will allow the country to take a step forward towards the "end of the pandemic."

The intention of the Spanish government is for the vaccination process to begin next January and for a large part of the population to be vaccinated during the first half of 2021. Sánchez did not want to specify which groups will be the first to receive the vaccine but indicated that groups such as health workers and the elderly would be prioritised. 

The president warned that the coming winter months will be "very hard" but also added that "the roadmap" is drawn up. Referring to Christmas festivities, he said this year will be different. "We will make common recommendations for all regions," he said.